Minocycline compounds for biodefense
US-2020330489-A1 · Oct 22, 2020 · US
Cross-Sectional Technologies
Cross-Sectional Technologies · Cooperative Patent Classification (CPC)
General tagging of emerging or interdisciplinary technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | Y02A50/475 |
| Official title | — |
| Display label | Cross-Sectional Technologies (mapped technology topic) |
| Total patents | 90 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity appears to be declining based on the most recent years.
| Year | Patents |
|---|---|
| 2018 | 8 |
| 2019 | 45 |
| 2020 | 37 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Beta-lactamase inhibitors
US-2020317698-A1 · Oct 8, 2020 · US
Amphiphile-Polymer Particles
US-2020206145-A1 · Jul 2, 2020 · US
Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
US-10676510-B2 · Jun 9, 2020 · US
Amphiphile-polymer particles
US-10583091-B2 · Mar 10, 2020 · US
Altering microbial populations & modifying microbiota
US-2020068901-A1 · Mar 5, 2020 · US
Substituted Urea Depsipeptide Analogs as Activators of the CLPP Endopeptidase
US-2020031872-A1 · Jan 30, 2020 · US
Altering microbial populations and modifying microbiota
US-10506812-B2 · Dec 17, 2019 · US
Crystalline diacylhydrazine and the use thereof
US-10501405-B2 · Dec 10, 2019 · US
Synergistic Bacterial Compositions and Methods of Production and Use Thereof
US-2019350988-A1 · Nov 21, 2019 · US
Altering microbial populations and modifying microbiota
US-10463049-B2 · Nov 5, 2019 · US
Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
US-10457707-B2 · Oct 29, 2019 · US
Engineered polypeptides for antigen delivery
US-10450352-B2 · Oct 22, 2019 · US
Potent phthalate inhibitors of aspartate N-acetyltransferase and selective aspartate pathway inhibitors
US-10449168-B2 · Oct 22, 2019 · US
Targeted gene delivery for dendritic cell vaccination
US-2019316153-A1 · Oct 17, 2019 · US
Targeted enzymatic degradation of quorum-sensing peptides
US-2019298872-A1 · Oct 3, 2019 · US
Nucleotide and Nucleoside Therapeutic Compositions and Uses Related Thereto
US-2019298750-A1 · Oct 3, 2019 · US
Methods and pharmaceutical compositions for the treatment of respiratory tract infections
US-10426816-B2 · Oct 1, 2019 · US
Immunoprotective primary mesenchymal stem cells and methods
US-2019282694-A1 · Sep 19, 2019 · US
Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
US-10413577-B2 · Sep 17, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC Y02A50/475?
- CPC Y02A50/475 is the Cooperative Patent Classification code for “Cross-Sectional Technologies.”
- How many patents are filed under CPC Y02A50/475 (Cross-Sectional Technologies)?
- Our database includes 90 publications tagged with this CPC code.
- Is patent activity under CPC Y02A50/475 growing?
- Publication counts under this code: 45 in 2019 vs 37 in 2020 (latest complete years).